Boehringer Ingelheim: WSC 2018 – Secondary stroke Prevention: new Evidence that Demands a Verdict

1) Stroke prevention in AF: latest insights on NOACs
Richard Bernstein, USA

2) Every minute counts: dabigatran reversal in neurological emergencies
Thorsten Steiner, Germany

LEAVE YOUR COMMENT

Your email address will not be published.